L’Oréal CEO Links GLP-1 Weight Loss Medications to Rising Skin Care Demand

Cosmetics Business reports that Nicolas Hieronimus, CEO of L’Oréal, has identified weight loss drugs as a primary catalyst for shifts in consumer beauty habits. During a recent investor call, Hieronimus detailed how the company is positioning specific products to address physical

Cosmetics Business reports that Nicolas Hieronimus, CEO of L’Oréal, has identified weight loss drugs as a primary catalyst for shifts in consumer beauty habits. During a recent investor call, Hieronimus detailed how the company is positioning specific products to address physical